Schedule 13G ownership disclosure

CELLECTAR BIOSCIENCES INC

Common Shares · CUSIP: 15117F500

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Rosalind Advisors, Inc.

    Shares: 247,715.00 · Class: 5.5%

  • SALAMON STEVEN A J

    Shares: 247,715.00 · Class: 5.5%

  • Aharon Gil

    Shares: 247,715.00 · Class: 5.5%

  • Rosalind Master Fund L.P.

    Shares: 185,036.00 · Class: 4.1%

  • Rosalind Opportunities Fund I L.P.

    Shares: 62,678.00 · Class: 1.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001622627-26-000002
Form type
SCHEDULE 13G/A
Filer
Cellectar Biosciences, Inc.
CIK
CIK 1279704
Filed
Feb 10, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub